Total Payments
$29,207
2021 Payments
$92.03
Companies
27
Transactions
208
Medicare Patients
669
Medicare Billing
$110,090
Payment Breakdown by Category
Consulting$17,627 (60.4%)
Travel$4,988 (17.1%)
Food & Beverage$4,003 (13.7%)
Other$2,500 (8.6%)
Research$68.92 (0.2%)
Education$20.24 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,627 | 5 | 60.4% |
| Travel and Lodging | $4,988 | 24 | 17.1% |
| Food and Beverage | $4,003 | 174 | 13.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $2,500 | 2 | 8.6% |
| Unspecified | $68.92 | 1 | 0.2% |
| Education | $20.24 | 2 | 0.1% |
Payments by Type
General
$29,139
207 transactions
Research
$68.92
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $20,734 | 71 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $5,197 | 8 | $0 (2018) |
| Shionogi Inc | $1,285 | 8 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $657.48 | 40 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $250.22 | 18 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $184.15 | 14 | $0 (2019) |
| Amgen Inc. | $177.10 | 10 | $0 (2021) |
| Allergan, Inc. | $173.55 | 10 | $0 (2020) |
| Genentech, Inc. | $68.92 | 1 | $0 (2020) |
| Takeda Pharmaceuticals U.S.A., Inc. | $67.67 | 4 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $92.03 | 4 | Amgen Inc. ($27.53) |
| 2020 | $1,216 | 18 | GlaxoSmithKline, LLC. ($932.09) |
| 2019 | $12,069 | 65 | GlaxoSmithKline, LLC. ($11,533) |
| 2018 | $13,942 | 77 | GlaxoSmithKline, LLC. ($8,123) |
| 2017 | $1,889 | 44 | Shionogi Inc ($1,285) |
All Payment Transactions
208 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/18/2021 | Novo Nordisk Inc | RYBELSUS (Drug), Ozempic | Food and Beverage | In-kind items and services | $12.35 | General |
| Category: Diabetes | ||||||
| 10/29/2021 | Biohaven Pharmaceuticals, Inc. | NURTEC ODT (Drug) | Food and Beverage | Cash or cash equivalent | $26.86 | General |
| Category: PRIMARY CARE | ||||||
| 06/01/2021 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: Bone Health | ||||||
| 02/02/2021 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $25.29 | General |
| 10/21/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $19.92 | General |
| Category: Respiratory | ||||||
| 10/08/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: RESPIRATORY | ||||||
| 09/15/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $20.74 | General |
| 08/05/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $13.73 | General |
| Category: ENDOCRINOLOGY | ||||||
| 08/05/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/13/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), ANORO ELLIPTA | Food and Beverage | In-kind items and services | $17.58 | General |
| Category: RESPIRATORY | ||||||
| 06/09/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $0.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/02/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.61 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 03/12/2020 | Allergan, Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: NEUROSCIENCE | ||||||
| 03/03/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: Respiratory | ||||||
| 02/28/2020 | Seqirus USA Inc | Fluad (Biological), FLUCELVAX QUADRIVALENT (MULTI-DOSE VIAL) | Food and Beverage | In-kind items and services | $18.97 | General |
| Category: Vaccines | ||||||
| 02/20/2020 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $900.00 | General |
| Category: RESPIRATORY | ||||||
| 02/13/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/05/2020 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $16.57 | General |
| 01/21/2020 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug) | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 01/14/2020 | Merck Sharp & Dohme Corporation | JANUVIA (Drug), JANUMET, BELSOMRA | Food and Beverage | In-kind items and services | $14.85 | General |
| Category: ENDOCRINOLOGY | ||||||
| 01/13/2020 | Genentech, Inc. | Xofluza (Drug) | — | Cash or cash equivalent | $68.92 | Research |
| Study: TRANSMISSION STUDY HOUSEHOLD • Category: Virology & Specialty Care | ||||||
| 01/09/2020 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $14.78 | General |
| 12/19/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.96 | General |
| 12/17/2019 | Allergan Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.32 | General |
| Category: NEUROSCIENCE | ||||||
| 12/11/2019 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $15.40 | General |
| Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| TRANSMISSION STUDY HOUSEHOLD | Genentech, Inc. | $68.92 | 1 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 176 | 295 | $103,545 | $28,286 |
| 2022 | 5 | 128 | 201 | $69,623 | $21,277 |
| 2021 | 5 | 198 | 365 | $57,947 | $36,609 |
| 2020 | 5 | 167 | 285 | $46,146 | $23,918 |
Total Patients
669
Total Services
1,146
Medicare Billing
$110,090
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 46 | 108 | $52,488 | $13,274 | 25.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 101 | $34,946 | $8,676 | 24.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 31 | 31 | $10,943 | $4,031 | 36.8% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 20 | 20 | $3,740 | $1,516 | 40.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 20 | 21 | $966.00 | $651.84 | 67.5% |
| 99473 | Education and training to self measure blood pressure | Office | 2023 | 11 | 14 | $462.00 | $136.89 | 29.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 34 | 75 | $33,330 | $9,716 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 40 | 72 | $23,408 | $6,334 | 27.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 31 | 31 | $10,331 | $4,110 | 39.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 11 | 11 | $2,002 | $753.94 | 37.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 12 | 12 | $552.00 | $362.76 | 65.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 68 | 171 | $27,018 | $15,854 | 58.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 47 | 109 | $21,409 | $14,373 | 67.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 41 | 41 | $8,200 | $5,558 | 67.8% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent | Office | 2021 | 21 | 22 | $660.00 | $438.02 | 66.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 21 | 22 | $660.00 | $385.66 | 58.4% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 45 | 102 | $18,666 | $10,027 | 53.7% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 59 | 120 | $18,960 | $8,845 | 46.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 39 | 39 | $7,800 | $4,611 | 59.1% |
| 90688 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 12 | 12 | $360.00 | $230.04 | 63.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 12 | 12 | $360.00 | $205.68 | 57.1% |
About Dr. Flory Kreutter, MD
Dr. Flory Kreutter, MD is a Family Medicine healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538115134.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Flory Kreutter, MD has received a total of $29,207 in payments from pharmaceutical and medical device companies, with $92.03 received in 2021. These payments were reported across 208 transactions from 27 companies. The most common payment nature is "Consulting Fee" ($17,627).
As a Medicare-enrolled provider, Kreutter has provided services to 669 Medicare beneficiaries, totaling 1,146 services with total Medicare billing of $110,090. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Denver, CO
- Active Since 05/25/2006
- Last Updated 04/05/2012
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1538115134
Products in Payments
- TRELEGY ELLIPTA (Drug) $7,669
- SOLIQUA (Drug) $5,197
- NUCALA (Biological) $3,920
- JANUVIA (Drug) $190.50
- SYMBICORT (Drug) $178.02
- FARXIGA (Drug) $153.98
- BEVESPI AEROSPHERE (Drug) $150.69
- BREO (Drug) $146.01
- ANORO (Drug) $138.31
- Aimovig (Biological) $74.13
- Xofluza (Drug) $68.92
- Trintellix (Drug) $67.67
- STIOLTO RESPIMAT (Drug) $63.53
- VRAYLAR (Drug) $61.80
- Prolia (Biological) $58.13
- AC2 (Device) $47.23
- BELSOMRA (Drug) $46.56
- XARELTO (Drug) $44.84
- Hetlioz (Drug) $40.10
- FASENRA (Drug) $39.11
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Denver
Dr. Ethan Lazarus, M.d, M.D
Family Medicine — Payments: $534,416
Family Medicine $534,416
Mark Deutchman, Md, MD
Family Medicine — Payments: $328,050
Family Medicine $328,050
Dr. Mia Scott, Do, DO
Family Medicine — Payments: $78,002
Family Medicine $78,002
Gerald Ahigian, M.d, M.D
Family Medicine — Payments: $18,168
Family Medicine $18,168
Susane Habashi-Ahigian, M.d, M.D
Family Medicine — Payments: $17,080
Family Medicine $17,080
Dr. Khoi Nguyen, D.o, D.O
Family Medicine — Payments: $14,000
Family Medicine $14,000